Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound

A compound and alkyl technology, applied in the field of compounds with MEK inhibitory function and their preparation, can solve the problems of low kinase selectivity, large toxic and side effects, and inability to produce specific effects, etc.

Inactive Publication Date: 2013-03-13
PEKING UNIV
View PDF2 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since this inhibitor is not highly selective for kinases and cannot produce specific effects, it may cause greater toxicity and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound
  • Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound
  • Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] Example 1. Synthesis of 3-benzyl-4-methyl-7-dimethylcarbamate coumarin (Compound M2)

[0071] first step

[0072] Slowly add sodium metal (50mmol, 1.15g) to 20ml of absolute ethanol. After sodium alkoxide is formed, add 50mmol of ethyl acetoacetate under stirring at 80°C and continue stirring for 10 minutes; when the reactant is boiled and refluxed, add 55mmol of bromine dropwise Bian anhydrous ethanol solution, heated to reflux until the reactants are almost neutral. Cool, filter to remove solid sodium bromide, dry the filtrate with anhydrous magnesium sulfate, and separate by column chromatography (petroleum ether: ethyl acetate = 50:1) (v / v) to obtain ethyl 3-benzyl acetoacetate, a yellow oily liquid 7.17g, the yield was 65.1%. 1 H NMR(300MHz, CDCl 3 ):δ1.16-1.21(t,J=7.1Hz,3H,CH 3 ), 2.17(s,1H,CH 3 ),3.14-3.16(d,J=7.5Hz,2H,PhCH 2 ), 3.76-3.81(t,J=7.5Hz,1H,CH),4.09-4.17(d,J=7.2Hz,2H,C H 2 CH 3 ), 7.16-7.28 (m, 5H, PhH).

[0073] Second step

[0074] Dissolve resorcinol (5mm...

Embodiment 2

[0077] Example 2. Synthesis of 3-benzyl-4-methyl-6-chloro-7-dimethylcarbamate coumarin (Compound M4)

[0078] first step

[0079] Dissolve 4-chlororesorcinol (5mmol, 0.72g) and ethyl 3-benzylacetoacetate (5mmol, 1.10g) in 11ml of 70% sulfuric acid, and react at room temperature for 24h. Ice water was added to the mixture solution to precipitate a solid, which was filtered and washed with water to obtain a crude product. The crude product was recrystallized with ethanol to obtain 0.652 g of 3-benzyl-4-methyl-6-chloro-7-hydroxycoumarin (compound M3), a white powder, with a yield of 43.5%, mp: 261-263°C. 1 HNMR(400MHz,DMSO):δ2.40(s,3H,CH 3 ),3.93(s,2H,CH 2 ), 6.89 (s, 1H, PhH), 7.15-7.28 (m, 5H, PhH), 7.79 (s, 1H, PhH), 11.26 (s, 1H, OH).

[0080] Second step

[0081] 3-benzyl-4-methyl-6-chloro-7-hydroxycoumarin (1mmol, 0.30g) was dissolved in 12ml DMF, sodium hydride (1.25mmol, 0.038g) was added under nitrogen protection, and reacted at room temperature for 30 minutes , Add N,N-dimeth...

Embodiment 3

[0082] Example 3. Synthesis of 3-p-fluorobenzyl-4-methyl-7-dimethylcarbamate coumarin (Compound M5)

[0083] first step

[0084] Add ethyl acetoacetate (10mmol, 1.26ml) to 3.76ml (10mmol) 21% sodium ethoxide solution, and reflux at 80℃ for reaction. When the reactant is slightly boiling, add 4-fluorobromide ethanol solution dropwise, continue React until the solution is almost neutral. Cool, filter to remove solid sodium bromide, dry the filtrate with anhydrous magnesium sulfate, and separate by column chromatography (petroleum ether: ethyl acetate = 50:1) (v / v) to obtain 1.41 g of ethyl 3-p-fluorobenzyl acetoacetate , Yellow oily liquid, yield 59%.

[0085] 1 H NMR(400MHz, CDCl 3 ):δ1.18-1.23(t,J=7.2Hz,3H,CH 2 C H 3 ), 2.12(s,3H,C H 3 CO),3.11-3.14(dd,J=1.2,7.2Hz,2H,CH 2 Ph),3.70-3.75(t,J=7.6Hz,1H,CH),4.12-4.16(ddd,J=1.2,7.2,11.6Hz,2H,C H 2 CH 3 ), 6.93-6.98 (m, 2H, PhH), 7.12-7.16 (m, 2H, PhH).

[0086] Second step

[0087] Dissolve resorcinol (3.43mmol, 0.377g) and ethyl 3-p-fluor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound with an MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as a preparation method and application of the compound. The structure of the compound disclosed by the invention is as shown in a formula (I). The preparation method of the compound disclosed by the invention comprises the steps of forming a coumarin ring by adopting a Pechmann reaction mainly and carrying out structural modification of different sites. In the binding experiment of the compound disclosed by the invention and MEK, the binding activity is up to 54.57nM; the anti-proliferation effect IC50 (half maximal inhibitory concentration) value on the melanoma cell A375 is up to 1.23 micrometers; the anti-proliferation effect IC50 value on the colon cancer cell HT-29 is up to 2.13 micrometers; and the activity is higher than that of a positive control U0126. The novel structure type coumarins compound with the MEK inhibiting function shows good MEK binding activity, MEK inhibiting activity, ERK (Extracellular signal Regulated Kinase) pathway inhibiting activity, anti-tumor effect and antiviral effect and has broad application value. The formula (I) is as shown in the specification.

Description

Technical field [0001] The invention relates to a compound and a preparation method and application thereof, in particular to a compound with MEK inhibitory function and a preparation method and application thereof. Such compounds have obvious anti-tumor and anti-viral effects, so they may be used in the treatment of tumors and viral diseases. Background technique [0002] Mitogen-activated protein kinase (MAPK) is an important protein kinase discovered in the mid-1980s and is an important core signaling pathway in cells. The MAPK pathway is mainly divided into four types of sub-families: extracellular signal-regulated kinase (ERK) pathway, JNK pathway, p38 pathway and ERK5 pathway. The ERK pathway is an important family of the MAPK pathway. It is mainly composed of three core protein kinases Raf, MEK (Mitogen-activated and Extracellular signal-regulated Kinase) and ERK, which are activated sequentially to form an accurate and efficient signal network pathway. Play an important...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D311/16C07D417/04A61P35/00A61P31/12A61P31/22
Inventor 徐萍彭宜红王超牛彦张浩许凤荣
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com